Pharmacy news
- 06/07/2022 Authorization required for select filgrastim drugs starting Aug 1
- Site of service restrictions for oncology infusions
- 05/04/2022: Formulary changes coming July 1
- 05/02/2022 Specialty drug savings program launching July 1
- 03/28/2022: Retacrit supply shortage expected soon
- 03/01/2022: Site of service restrictions applied for infusions services April 1
- Our pharmacists are calling your patients about medication adherence
- 10/29/2021: Jan. 1 2022 formulary changes
- 09/30/2021: Authorization requirements added for select Medicare medical drugs
- 08/11/2021: New preferred products for Medicare Part B drugs start Oct. 14
- 04/23/2021: July 1 formulary changes
- 01/27/2021: Feb. 1 Medicaid Formulary Changes
- 01/21/2021 Preferred biosimilars for pegfilgrastim effective April 1
- 01/06/2021 New scam alert: fraudulent prescription and CMN requests
- 12/30/2020 Anagrelide Capsules drug recall
- 12/11/2020 Drug recall: Paroex Oral Rinse
- 10/27/2020 Jan. 1 2021 formulary changes
- 10/20/2020 Nature Throid and WP Thyroid recall
- 08/13/2020 FDA recalling select desmopressin nasal spray products
- 08/12/2020 Coming August 31: ePA for pharmacy
- 07/31/2020 Medicaid Health Plans transitioning to Preferred Drug List
- 07/17/2020 Metformin ER recall
- 06/09/2020 Update to July 1 commercial formulary changes
- 05/04/2020 We're removing prior authorization requirements for infliximab products
- 04/30/2020 July 1, 2020 formulary changes
- 04/29/2020 Biosimilars preferred over Herceptin, Avastin and Rituxan
- 04/14/2020 Ranitidine recall
- 03/16/2020 We're working hard to reduce pharmacy wait times
- 12/23/2019: Flublok vaccine now covered for commercial members
- 10/28/2019: Jan. 1 commercial and Medicare formulary updates
- 09/06/2019: Michigan Medicaid formulary changes coming Oct. 1
- 07/30/2019: Step therapy added for select Medicare Part B drugs effective Oct. 1, 2019
- 07/03/2019: Medicaid formulary changes for select asthma drugs effective Aug. 1, 2019
- 04/29/2019: Commercial formulary updates coming July 1
- 01/02/2019: Reminder: Effective Jan. 1, step therapy added for Medicare Part B drugs
- 12/20/2018: Voluntary recall of amlodipine
- 12/19/2018: Medicare Part D Opioid Policies from CMS effective Jan. 1, 2019
- 10/31/2018: Recent and upcoming formulary changes
- 08/30/2018: Michigan Medicaid Formulary Changes coming Oct. 1
- 08/06/2018: Valsartan blood pressure medication recalled
- 06/12/2018: Opioids policy updated
- 05/07/2018: July 1 pharmacy and formulary changes
- 05/02/2018: Biosimilars preferred over Remicade®
- 04/04/2018: January formulary updates
- 03/19/2018: January formulary updates
- 12/20/2017: MQIC releases guidelines for opioid prescribing
- 12/13/2017: November formulary updates
- 11/14//2017: Pharmacy benefit changes for 2017 and 2018
- 11/02/2017: Medicaid common formulary changes as of Oct. 1, 2017
- 10/13/2017: Medicaid narrow pharmacy network as of Dec. 1
- 08/14/2017: Topical corticosteroid formulary changes
- 08/02/2017: Opioid coverage changes start Sept. 1
- 12/08/2017: Hyaluronic acid derivatives coverage change Jan. 1